All tenders
75F40126C00106

Genome Sequencing and Characterization of BDBV from Patient Samples

Department of Health and Human Services · United States

This contract has been awarded. Browse open opportunities
View Source

Time Left to Bid

Awarded

AwardedEducation & TrainingFederal

Basic information

Reference number
75F40126C00106
Government level
Federal
Solicitation type
Education & Training
Title
Genome Sequencing and Characterization of BDBV from Patient Samples
Source ID
CONT_AWD_75F40126C00106_7524_-NONE-_-NONE-

Details

Location
United States

Summary

This project involves sequencing and characterizing the genome of BDBV (a pathogenic virus) from patient samples collected during an active outbreak. The scope includes genomic analysis of up to 1,000 patient samples to understand viral variants, transmission patterns, and outbreak dynamics. The work supports public health response and epidemiological investigation by the FDA and Department of Health and Human Services.

Description

EO 14398 - THIS PROJECT SHALL SEQUENCE AND CHARACTERIZE THE GENOME OF BDBV IN THE CURRENT OUTBREAK, WITH A SPECIFIC TARGET TO SEQUENCE AND ANALYZE THE BDBV GENOME FROM AS MANY AS 1,000 PATIENTS Awarded to: UNIVERSITY OF LIVERPOOL Sub-agency: Food and Drug Administration Contract type: DEFINITIVE CONTRACT

Dates

Publication
2026/08/21 12:00:00 AM UTC
Closing date
2027/02/20 12:00:00 AM UTC

Estimated value

$350K USD

Classification

Normalized category

Education & Training

Source: usaspending

Last updated 2026-09-05, 12:12:19 p.m.

Data refreshed every 2 hours